## Abstract A high throughput accurate assay for antiβSARSβCoV IgG detection is needed for largeβscale epidemiological studies. The evaluation of a commercial recombinant nucleocapsid proteinβbased microtitre plate enzyme immunoassay, ELISARSβ’ is described. The results on 150 sera from SARS patient
β¦ LIBER β¦
Establishment of a reference panel for the detection of anti-SARS-CoV antibodies
β Scribed by Chunyu Liu; Xiuhua Li; Chuntao Zhang; Sihong Xu; Yiming Shao; Hui Zhuang; Xiaoyan Che; Yan Qiu; Hongzhang Yin; Defu Li; Youchun Wang
- Book ID
- 113491619
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 393 KB
- Volume
- 35
- Category
- Article
- ISSN
- 1045-1056
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Evaluation of a recombinant nucleocapsid
β
Paul K.S. Chan; Esther Y.M. Liu; Danny T.M. Leung; Jo L.K. Cheung; C.H. Ma; Fran
π
Article
π
2004
π
John Wiley and Sons
π
English
β 84 KB
A rapid point of care immunoswab assay f
β
Sriram Kammila; Dipankar Das; Pravin K. Bhatnagar; Hoon H. Sunwoo; Gustavo Zayas
π
Article
π
2008
π
Elsevier Science
π
English
β 548 KB
Establishment of the eukaryotic cell lin
β
Guo-hui Chang; Andrew Dividson; Lei Lin; Matt Wilson; Stuart G. Siddell; Qing-yu
π
Article
π
2010
π
SP Wuhan Institute of Virology, CAS
π
English
β 468 KB
Establishment of a cell line panel for t
Establishment of a cell line panel for the detection of antibodies against human platelet antigen 4b
β
Tomoya Hayashi; Etsuko Amakishi; Masayasu Inoue; Fumiya Hirayama
π
Article
π
2011
π
Carden Jennings Publishing
π
English
β 334 KB
Evaluation of a safe and sensitive Spike
β
Ivanus Manopo; Liqun Lu; Qigai He; Li Lian Chee; Shzu-Wei Chan; Jimmy Kwang
π
Article
π
2005
π
Elsevier Science
π
English
β 185 KB
Evaluation of a novel vesicular stomatit
β
Shuetsu Fukushi; Tetsuya Mizutani; Masayuki Saijo; Ichiro Kurane; Fumihiro Taguc
π
Article
π
2006
π
John Wiley and Sons
π
English
β 88 KB
Severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV) is the causative agent of SARS. The S protein of SARS-CoV is a major target for neutralizing antibodies (Nabs) in infected patients. We developed a neutralization assay using a recombinant vesicular stomatitis virus (VSV) bearing SARS-C